J
Joseph L. Roberts
Researcher at Duke University
Publications - 40
Citations - 4318
Joseph L. Roberts is an academic researcher from Duke University. The author has contributed to research in topics: Severe combined immunodeficiency & T cell. The author has an hindex of 25, co-authored 38 publications receiving 4114 citations. Previous affiliations of Joseph L. Roberts include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
Sarah M. Russell,Nahid Tayebi,Hiroshi Nakajima,M. C. Riedy,Joseph L. Roberts,M. Javad Aman,Thi-Sau Migone,Masayuki Noguchi,M. Louise Markert,Rebecca H. Buckley,John J. O'Shea,Warren J. Leonard +11 more
TL;DR: Observations indicate that the functions of γc are dependent on Jak3 and that Jak3 is essential for lymphoid development and signaling.
Journal ArticleDOI
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Rebecca H. Buckley,Sherrie E. Schiff,Richard I. Schiff,M. Louise Markert,Larry W. Williams,Joseph L. Roberts,Laurie Myers,Frances E. Ward +7 more
TL;DR: Transplantation of marrow from a related donor is a life-saving and life-sustaining treatment for patients with any type of severe combined immunodeficiency, even when there is no HLA-identical donor.
Journal ArticleDOI
Clinical efficacy and immune regulation with peanut oral immunotherapy.
Stacie M. Jones,Laurent Pons,Joseph L. Roberts,Amy M. Scurlock,Tamara T. Perry,Mike Kulis,Wayne G. Shreffler,Pamela H. Steele,Karen A. Henry,Margaret Adair,James M. Francis,Stephen R. Durham,Brian P. Vickery,Xiao-Ping Zhong,A. Wesley Burks +14 more
TL;DR: Microarray data suggest a novel role for apoptosis in OIT, which induces clinical desensitization to peanut, with significant longer-term humoral and cellular changes.
Journal ArticleDOI
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.
Rebecca H. Buckley,Richard I. Schiff,Sherrie E. Schiff,M. Louise Markert,Larry W. Williams,Terry O. Harville,Joseph L. Roberts,Jennifer M. Puck +7 more
TL;DR: Different SCID genotypes are associated with distinctive lymphocyte characteristics and the presence of NK function in ADA-deficient, autosomal recessive, and unknown type SCIDs, and lowNK function in a majority of gamma c and Jak3 SCIDs indicates that some molecular lesions affect T, B, and NK cells, others primarily T cells (ADA deficiency), and others just T and B cells.
Journal ArticleDOI
Jak3 and the pathogenesis of severe combined immunodeficiency.
John J. O'Shea,Matthew Husa,Denise Li,Sigrun R. Hofmann,Wendy T. Watford,Joseph L. Roberts,Rebecca H. Buckley,Paul S. Changelian,Fabio Candotti +8 more
TL;DR: The normal actions of the gammac cytokines, the pathogenesis and treatment protocols for SCID, and finally, the production of a new, selective Jak3 inhibitor capable of preventing transplant rejection in two animal models are discussed.